⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 4, 2026International Journal of Dermatology

Prevalence of Regulatory Safety Risk Factors Among Adolescents and Adults With Atopic Dermatitis Receiving Advanced Systemic Therapies: An International Real‐World Study

José Miguel Alvarenga Jensen Yeung Vimal H. Prajapati Simone Ribero Anna Balato Angelo Valerio Marzano Maria João Cruz Maria João Paiva Lopes Elizabeth Lazaridou J.M. Carrascosa Pedro Simões Farinha Bruno Duarte Siddhartha Sood Brian D. Rankin Michela Ortoncelli Stefano Caccavale Silvia Mariel Ferrucci Gilberto Pires da Rosa A. Daponte Gianmarco Silvi Ketty Peris Niccolò Gori Pedro Herranz Francesca Prignano Antonios G.A. Kolios Natalia Rompoti Stamatios Gregoriou Spyridon Gkalpakiotis Andrea Chiricozzi Tiago Torres

View Full Paper

Ask AI

Bookmark

Share

Key Points

To assess the prevalence of regulatory safety risk factors among individuals with atopic dermatitis receiving advanced systemic therapies.
Conducted an international real-world study
Included adolescents and adults with atopic dermatitis
Analyzed data regarding regulatory safety risk factors and treatment outcomes
Found varying prevalence of regulatory safety risk factors among participants
Identified specific risk factors linked to different systemic therapies

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

International real-world study finds regulatory safety risk factors in adolescents and adults with atopic dermatitis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Alvarenga et al. (2026) studied this question.

synapsesocial.com/papers/6a75abca847ab6d26c02064c https://doi.org/10.1111/ijd.70617

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Disease burden and patient characteristics associated with systemic therapy utilization among adults with atopic dermatitis: data from CorEvitas Atopic Dermatitis Registry2024 · 5 citations
2Interpreting Incident Psychiatric Diagnoses in Adolescents With Atopic Dermatitis: The Importance of Baseline ObservabilityOriginal Research · 2026
3Patient‐Reported Impact of Atopic Dermatitis on Pediatric and Adolescent Patients With Moderate‐To‐Severe Disease: Results of a Real‐World, Cross‐Sectional SurveyCross-Sectional Study · 2025 · 7 citations
4Factors associated with the health-related quality of life of adolescents with atopic dermatitis in South Korea: a cross-sectional studyCross-Sectional Study · 2026
5Atopic dermatitis in adolescents: Clinical and psychosocial challenges – A narrative reviewNarrative Review · 2026